K Terbimax Cream contains Terbinafine 1% w/w, an antifungal agent belonging to the allylamine class, indicated for the topical treatment of superficial fungal infections of the skin. Terbinafine exerts its antifungal effect by inhibiting the enzyme squalene epoxidase, which is essential for ergosterol synthesis, a critical component of fungal cell membranes. This disruption leads to increased cellular permeability and ultimately fungal cell death. K Terbimax Cream is effective against dermatophytes, yeasts, and molds responsible for conditions such as tinea corporis, tinea cruris, tinea pedis, and candidiasis. The cream formulation allows for targeted application, minimizing systemic absorption and reducing the risk of systemic side effects. It is typically applied once or twice daily to the affected area and surrounding skin, with treatment duration varying depending on the infection type and severity, generally ranging from 1 to 4 weeks. Patients should be advised to apply the cream to clean, dry skin and to continue treatment for the full prescribed duration to prevent recurrence. K Terbimax Cream is contraindicated in individuals with known hypersensitivity to Terbinafine or any cream excipients. Adverse effects are generally mild and may include local irritation, burning, or erythema.